Portfolio

Anaveon

CEO Andreas Katopodis

Anaveon is a clinical stage, biopharmaceutical company that develops biologics to modulate the function of cytokines and provide substantial therapeutic benefit to cancer patients.

Anaveon is a clinical stage, biopharmaceutical company, based in Switzerland, that develops biologics to modulate the function of cytokines and provide substantial therapeutic benefit to cancer patients.

The company's vision is to develop novel immune therapies benefiting patients suffering from a wide variety of diseases with immune pathology.

Human Health

Anaveon

CH

Anaveon AG
Technologiepark Basel
Hochbergerstrasse 60C
4057 Basel

Industry

Biotech

Status

Current

Location

Switzerland